Ang-2 is a potential molecular marker for lymphatic metastasis and better response to bevacizumab therapy in ovarian cancer.

J Cancer Res Clin Oncol · 2023 · PMC10620258 · PMID 37684509

Europe PMC DOI

hedged sentences

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

did not reach statistical significancep = 0.053so close (0.05 < p ≤ 0.1)

However, these findings did not reach statistical significance ( p = 0.053, Fig. 3 A).

also in 111,027 other papers

a strong trendno p-value reported

Here, we could corroborate the predictive value of Ang-2 and note a strong trend toward longer OAS in patients with high Ang-2 levels treated with bevacizumab.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.